Herbal Groups advertising referred to FDA for review
NEW YORK The National Advertising Division of the Council of Better Business Bureaus on Tuesday referred advertising published by Herbal Groups to the Federal Trade Commission and the Food and Drug Administration (FDA) for further review.
NAD, the advertising industry’s self-regulatory forum, had asked Herbal Groups to provide substantiation for health claims made for Prostalex Plus, which included: “Prostalex Plus has been shown in clinical studies to reduce the size of the prostate, leading to a reduced urge to urinate, improvement in urinary flow, improvement in erectile issues and increased sex drive.”
Further, NAD was concerned that “the Prostate Health Blog,” which is linked to the advertiser’s Web site and appears to be an independently written blog, is actually advertising by the company.
In response to the NAD inquiry, the advertiser submitted a study on Prostalex, but declined to participate in the NAD process. Pursuant to Section 2.9 of the NAD/NARB Procedures, NAD referred this matter to the FTC and FDA for review.
Nordic Naturals launches Omega Longevity
WATSONVILLE, Calif. Nordic Naturals on Monday announced the launch of Omega Longevity, purified fish oil high in omega-3 essential fatty acids combined with two antioxidants – resveratrol and green tea extract – for targeted nutritional support for healthy aging.
Omega Longevity offers 455-mg EPA, 315-mg DHA, 120 mg resveratrol and 500-mg of green tea extract per two soft gel serving. By combining the benefits of fish oil with these antioxidants, Omega Longevity helps protect cells and tissue from damage associated with aging, neutralizes harmful free radicals, optimizes cell membrane fluidity and supports long-term physical and cognitive health for optimal aging.
“Resveratrol has captured the attention of anti-aging researchers because it specifically inhibits the proposed biochemical processes of aging by working as a strong antioxidant, inhibiting lipid peroxidation, preventing cytotoxicity and acting as a chemopreventive agent,” stated Bradley West, Nordic Naturals research advisor.
Study shows parents speak to teens about OTC abuse
WASHINGTON A new Partnership/Metlife Parents Attitude Tracking Study indicates that 65% of parents are talking to their teens about the dangers of using over-the-counter cough and cold medicine to get high, up from 55% in 2007.
“We know that parents play a critical role in keeping their kids drug-free,” stated Linda Suydam, president of the Consumer Healthcare Products Association. “It is great news that more and more parents are exercising that power and talking to their kids about cough medicine abuse just as they would about any substance abuse behavior.”
Nationwide statistics from the National Institutes of Health’s Monitoring the Future study show a slight overall decline in teen cough medicine abuse. ”That is one of the reasons the Partnership is so committed to helping parents have these important conversations with their teens.”
“The data are encouraging, since we know that kids who learn a lot from their parents about the risks of drugs are up to 50% less likely to ever use drugs,” stated Steve Pasierb, president of the Partnership for a Drug-Free America.
CHPA works with the Partnership and other interested organizations on a number of initiatives targeting teen cough medicine abuse. All of the association’s efforts can be found on http://www.StopMedicineAbuse.org.
“Our member companies are steadfast in their commitment to prevent teen cough medicine abuse,” Suydam stated. “But we know that our work is far from over. With the help of such partners as the Partnership for a Drug-Free America, the Community Anti-Drug Coalitions of America, and D.A.R.E. America, we will continue our efforts to make sure all parents are aware of this substance abuse behavior and most importantly, talking with their children about it.”
The PATS-Parents 2008 is a nationally projectable survey of 1,004 parents of children in grades 4-12 and was conducted by the Partnership with major funding from MetLife Foundation.